FDA approves Vanda's drug for treatment of bipolar disorder

FDA approves Vanda's drug for treatment of bipolar disorder

Source: 
Reuters
snippet: 

The U.S. FDA approved Vanda Pharmaceuticals' (VNDA.O) drug to treat manic and mixed episodes associated with a type of bipolar disorder, the company said on Tuesday, marking the second approval for the treatment.